Ibuprofen + Diclofenac + Methyl-salicylate / Menthol + Placebo

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
25
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pain

Conditions

Pain

Trial Timeline

Mar 1, 2015 โ†’ May 1, 2015

About Ibuprofen + Diclofenac + Methyl-salicylate / Menthol + Placebo

Ibuprofen + Diclofenac + Methyl-salicylate / Menthol + Placebo is a phase 1 stage product being developed by Futura Medical for Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02666846. Target conditions include Pain.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02666846Phase 1Completed